Claris Bio's journey toward treating neurotrophic keratitis
Season 2, Episode 38, Apr 25, 05:34 PM
Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.